Nippon India Pharma Fund - Direct Growth
Summary Info Open Free MF account now
Login to invest now
| Fund Name | : | Nippon India Mutual Fund |
| Scheme Name | : | Nippon India Pharma Fund - Direct Growth |
| AMC | : | Nippon India Mutual Fund |
| Type | : | Open |
| Category | : | Equity - Pharma |
| Launch Date | : | 01-Jan-13 |
| Fund Manager | : | Sailesh Raj Bhan |
| Net Assets (Rs. cr) | : | 3910.67 |
Nippon India Pharma Fund - Direct Growth - NAV Details
| NAV Date | : | 25-Nov-20 |
| NAV [Rs.] | : | 248.51 |
| Buy/Resale Price [Rs.] | : | 0 |
| Sell/Repurchase Price [Rs.] | : | 0 |
| Entry Load % | : | |
| Exit Load % | : | Nil |
Nippon India Pharma Fund - Direct Growth - NAV Chart
Nippon India Pharma Fund - Direct Growth - Performance(%)
* returns above 1 yr. are annualized
| 1w | 1m | 3m | 6m | 1y | 3y | 5y | Since INC | |
| Scheme Returns | 2.58 | 3.74 | 5.20 | 26.83 | 54.41 | 20.42 | 10.64 | 17.42 |
| Category Avg | 1.55 | 2.04 | 4.56 | 27.97 | 54.13 | 16.80 | 7.94 | 22.13 |
| Category Best | 2.58 | 3.74 | 6.06 | 39.47 | 68.93 | 20.42 | 10.64 | 37.80 |
| Category Worst | 0.65 | 0.53 | 2.64 | 21.34 | 42.12 | 12.54 | 4.55 | 6.81 |
Nippon India Pharma Fund - Direct Growth - Latest Dividends
| Dividends | Bonus | |
| Ratio | NA | NA |
| Date | NA | NA |
Nippon India Pharma Fund - Direct Growth - Investment Details
| Min. Investment(Rs.) | : | 5000 |
| Increm.Investment(Rs.) | : | 1 |
In & Out
| In | |
| Name of the Company | No of shares |
| No Data Found | |
| Out | |
| Name of the Company | No of shares |
| No Data Found | |
Fund Holdings
| Asset Type | Instrument Name | Industry | Net Assets(%) | No of Shares | Mkt Value(Cr.) |
| Equity & Equity related Investments | |||||
| Equity | Divi's Lab. | Pharmaceuticals | 9.67 | 1,200,075.00 | 377.07 |
| Equity | Sun Pharma.Inds. | Pharmaceuticals | 9.56 | 8,000,976.00 | 372.65 |
| Equity | Aurobindo Pharma | Pharmaceuticals | 9.33 | 4,710,000.00 | 363.92 |
| Equity | Cipla | Pharmaceuticals | 9.09 | 4,700,000.00 | 354.62 |
| Equity | Lupin | Pharmaceuticals | 8.86 | 3,800,025.00 | 345.52 |
| Equity | Dr Reddy's Labs | Pharmaceuticals | 7.52 | 600,000.00 | 293.32 |
| Equity | Thyrocare Tech. | Healthcare Services | 6.84 | 2,323,279.00 | 266.88 |
| Equity | Cadila Health. | Pharmaceuticals | 5.09 | 4,748,982.00 | 198.37 |
| Equity | Fortis Health. | Healthcare Services | 4.64 | 14,403,541.00 | 180.91 |
| Equity | Apollo Hospitals | Healthcare Services | 4.41 | 811,506.00 | 171.99 |
| Equity | Sanofi India | Pharmaceuticals | 3.59 | 175,000.00 | 140 |
| Equity | Narayana Hrudaya | Healthcare Services | 3.51 | 4,000,881.00 | 136.81 |
| Equity | Abbott India | Pharmaceuticals | 3.31 | 84,371.00 | 129.07 |
| Equity | Biocon | Pharmaceuticals | 2.28 | 2,203,178.00 | 88.92 |
| Equity | Indoco Remedies | Pharmaceuticals | 2.23 | 3,390,190.00 | 87.08 |
| Equity | Shilpa Medicare | Pharmaceuticals | 1.44 | 1,250,000.00 | 55.98 |
| Equity | Alkem Lab | Pharmaceuticals | 1.42 | 209,570.00 | 55.21 |
| Equity | Syngene Intl. | Pharmaceuticals | 1.39 | 1,012,877.00 | 54.18 |
| Equity | Torrent Pharma. | Pharmaceuticals | 1.32 | 200,000.00 | 51.34 |
| Equity | Pfizer | Pharmaceuticals | 0.67 | 52,746.00 | 26.29 |
| Equity | Health.Global | Healthcare Services | 0.36 | 1,162,723.00 | 13.96 |
| Derivative Investments | |||||
| Derivatives | Derivatives | -/- | 0.32 | 0.00 | 12.35 |
| Cash & Cash Equivalent | |||||
| Reverse Repo | TREPS | -/- | 4.56 | 0.00 | 177.73 |
| Cash & Cash Equivalent | Cash & Cash Equivalent | -/- | 0 | 0.00 | 0.05 |
| Net CA & Others | Net CA & Others | -/- | [1.41] | 0.00 | [54.52] |
Fund Manager Speak
Sachin Trivedi, Equity Fund Manager & Head of Research, UTI Asset Management Company
Growth will come back and people will take time to adjust, which is why we will spend the next 1-1.5 years in a consolidation phase....
Key Information
| Fund House | : Nippon India Mutual Fund |
| Incorporation Date | : 24-Feb-1995 |
| Total Assets Managed (Cr.) | : 201,301.77 |
| Trustee/s | : Nippon Life India Trustee |
| Chairman | : N/A |
| CEO / MD | : Mr. Sundeep Sikka |
| CIO | : N/A |
| President | : N/A |
| Director/s | : Mr. Takayuki Murai |
| Compliance Officer/s | : Mr. Muneesh Sud |
| Investor Service Officer/s | : Mr. Bhalchandra Joshi |
| Fund Manager/s | : Sailesh Raj Bhan |
Other Information
| Auditors | : N/A |
| Registered Office | : 4th Floor, Tower A, Peninsula Busines -s Park, Ganapatrao Kadam Marg Lower Parel (W), Mumbai - 400013. |
| Contact Nos | : 022-68087000 |
| Fax | : 022-68087097 |
| : customercare@nipponindiamf.com | |
| Website | : www.nipponindiamf.com |
